ExploreWatchlistsPricing
  1. US-listed companies
  2. NEUROCRINE BIOSCIENCES INC
  3. Financials
  4. Net income margin (%)

NEUROCRINE BIOSCIENCES INC (NBIX)

Market cap
$12.8B
P/E ratio
27.3x
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 202516.7+256.26%
Dec 31, 20194.7+0.38%
Dec 31, 20184.7-105.30%
Dec 31, 2017-88.2-90.62%
Dec 31, 2016-940.6+109.10%
Dec 31, 2015-449.8-Infinity%
Dec 31, 20140-100.00%
Dec 31, 2013-1,579-16797.76%
Dec 31, 20129.5-80.52%
Dec 31, 201148.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat